Clinical Trials Browser

Completed × INDUSTRY × Bone Marrow Failure Disorders × Clear all

NCT04618081 2025-07-08

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Bone Marrow Failure Disorders, Lymphoma, Lymphoma, Non-Hodgkin, Neutropenia